MIR877 Gene

HGNC Family Non-coding RNAs
Name microRNA 877
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMiR‐877 functions as a critical regulatory molecule in cancer by acting predominantly as a tumor suppressor. In several malignancies, including hepatocellular carcinoma, bladder, cervical, gastric, non‐small cell lung, prostate, esophageal, osteosarcoma, and breast cancers, down‐regulation or sequestration of miR‐877 through ceRNA networks (via circular RNAs, long non‐coding RNAs, and other sponges) results in the de‐repression of key oncogenic targets such as FOXM1, VEGFA, ATXN7L3, FGF2, GGCT, PMEPA1, ACP5, and CCNA2. This loss of miR‐877 control promotes cellular proliferation, migration, invasion, epithelial–mesenchymal transition, and therapy resistance, while genetic studies also implicate promoter variants in miR‐877 with altered cancer risk."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "15"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its role in cancer, miR‐877 also modulates inflammatory and differentiation processes in non‐malignant conditions. In IgA nephropathy, reduced miR‐877 levels are linked to enhanced production of pro‐inflammatory cytokines such as interleukin‑1β in mesangial cells. In acute respiratory distress syndrome and ischemic stroke, miR‐877–mediated targeting of regulators like CDKN1B contributes to dampening inflammatory cascades and promoting endothelial cell function. Moreover, in vascular smooth muscle cells and osteoblasts, miR‐877 influences cell proliferation and differentiation—via interactions with ceRNAs such as HOXA‑AS2 and targets including EIF4G2—thus impacting tissue repair and bone formation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "16", "end_ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nCollectively, these findings indicate that miR‐877 is a pivotal modulator whose loss or sequestration enhances oncogenic signaling and inflammation, while its restoration can inhibit tumor growth, metastasis, and aberrant inflammatory responses. As a central node in diverse ceRNA networks, miR‐877 holds promise both as a noninvasive biomarker for early cancer detection and as a therapeutic target for counteracting malignancy and inflammatory diseases."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}, {"type": "fg_f", "ref": "16"}, {"type": "fg_f", "ref": "3"}, {"type": "fg_f", "ref": "17"}, {"type": "fg_fs", "start_ref": "5", "end_ref": "8"}, {"type": "fg_f", "ref": "18"}, {"type": "fg_f", "ref": "21"}, {"type": "fg_fs", "start_ref": "9", "end_ref": "14"}, {"type": "fg_f", "ref": "19"}, {"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Xinli Huang, Jianjie Qin, Sen Lu "}, {"type": "b", "children": [{"type": "t", "text": "Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2015)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25973036"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25973036"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Shiqi Li, Yi Zhu, Zhen Liang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.10575"}], "href": "https://doi.org/10.18632/oncotarget.10575"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27429046"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27429046"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Jie Liang, Shujuan Zhang, Wei Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA DSCAM-AS1 contributes to the tumorigenesis of cervical cancer by targeting miR-877-5p/ATXN7L3 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20192061"}], "href": "https://doi.org/10.1042/BSR20192061"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31737900"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31737900"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jun Lu, Yao-Hui Wang, Changhwan Yoon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA circ-RanGAP1 regulates VEGFA expression by targeting miR-877-3p to facilitate gastric cancer invasion and metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2019.11.038"}], "href": "https://doi.org/10.1016/j.canlet.2019.11.038"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31811909"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31811909"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Hongtu Wang, Bo Wang, Tao Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A genetic variant in the promoter region of miR-877 is associated with an increased risk of hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Res Hepatol Gastroenterol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.clinre.2020.01.006"}], "href": "https://doi.org/10.1016/j.clinre.2020.01.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32113822"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32113822"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Xiao-Dan Guo, Nan Zhang, Lei Sha "}, {"type": "b", "children": [{"type": "t", "text": "miR-877-5p antagonizes the promoting effect of SP on the gastric cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasma (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4149/neo_2020_200502N480"}], "href": "https://doi.org/10.4149/neo_2020_200502N480"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32853022"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32853022"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Li-Juan Du, Long-Jun Mao, Rui-Jun Jing "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA DNAH17-AS1 promotes tumorigenesis and metastasis of non-small cell lung cancer via regulating miR-877-5p/CCNA2 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2020.09.047"}], "href": "https://doi.org/10.1016/j.bbrc.2020.09.047"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32981678"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32981678"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Xue Bai, Changjun He, Bicheng Fu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-877 contributes to decreased non-small cell lung cancer cell growth via the PI3K/AKT pathway by targeting tartrate resistant acid phosphatase 5 activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384101.2020.1839697"}], "href": "https://doi.org/10.1080/15384101.2020.1839697"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33222607"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33222607"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Yan Zhang, Huayun Zhu, Ning Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Linc00941 regulates esophageal squamous cell carcinoma via functioning as a competing endogenous RNA for miR-877-3p to modulate PMEPA1 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.203286"}], "href": "https://doi.org/10.18632/aging.203286"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34254950"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34254950"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Bin Yang, Huifeng Diao, Pu Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-877-5p exerts tumor-suppressive functions in prostate cancer through repressing transcription of forkhead box M1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.1989969"}], "href": "https://doi.org/10.1080/21655979.2021.1989969"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34654353"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34654353"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Mingji Chen, Zhi Li, Lei Cao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-877-3p inhibits tumor growth and angiogenesis of osteosarcoma through fibroblast growth factor 2 signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.1982305"}], "href": "https://doi.org/10.1080/21655979.2021.1982305"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34738872"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34738872"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Jing Wu, Zian Feng, Rui Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Integration of bioinformatics analysis and experimental validation identifies plasma exosomal miR-103b/877-5p/29c-5p as diagnostic biomarkers for early lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Med (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cam4.4788"}], "href": "https://doi.org/10.1002/cam4.4788"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35585716"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35585716"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Zhiguang Liu, Xinlian Wang, Liqiang Cao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-877-5p Inhibits Cell Progression by Targeting FOXM1 in Lung Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Can Respir J (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2022/4256172"}], "href": "https://doi.org/10.1155/2022/4256172"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35756697"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35756697"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Jinxiang Zhu, Hao Dai, Xiang Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA TRG-AS1 inhibits bone metastasis of breast cancer by the miR-877-5p/WISP2 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2023.154360"}], "href": "https://doi.org/10.1016/j.prp.2023.154360"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36801505"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36801505"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "LinZhu Yang, Yi Xiao, ShouJun Deng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Signal Transducer and Activator of Transcription 4-Induced Up-Regulated LINC01278 Enhances Proliferation and Invasion of Non-Small Cell Lung Cancer Cells via the MicroRNA-877-5p/Activating Transcription Factor 4 Axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tissue Eng Regen Med (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13770-024-00625-5"}], "href": "https://doi.org/10.1007/s13770-024-00625-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38466361"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38466361"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yan Liang, Guoqiang Zhao, Lin Tang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-100-3p and miR-877-3p regulate overproduction of IL-8 and IL-1β in mesangial cells activated by secretory IgA from IgA nephropathy patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2016.08.011"}], "href": "https://doi.org/10.1016/j.yexcr.2016.08.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27542871"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27542871"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "T-T Fan, Y-X Liu, X-C Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HOXA-AS2 accelerates the proliferation and migration and inhibits the apoptosis of vascular smooth muscle cells by absorbing miRNA-877-3p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202001_19934"}], "href": "https://doi.org/10.26355/eurrev_202001_19934"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31957850"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31957850"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Kaili Li, Zuoting Huang, Shijing Tian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-877-5p alleviates ARDS via enhancing PI3K/Akt path by targeting CDKN1B both in vivo and in vitro."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int Immunopharmacol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.intimp.2021.107530"}], "href": "https://doi.org/10.1016/j.intimp.2021.107530"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33735715"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33735715"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Si-Shuo Zhang, Ji-Wei Zhang, Kai-Xin Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hsa-miR-877-5p Expression in Acute Ischemic Stroke Based on Bioinformatics Analysis and Clinical Validation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Neurobiol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12035-023-03675-3"}], "href": "https://doi.org/10.1007/s12035-023-03675-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37837492"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37837492"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "YingChao Shen, Yang Zhang, Qiang Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-877-5p promotes osteoblast differentiation by targeting EIF4G2 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Orthop Surg Res (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13018-023-04396-y"}], "href": "https://doi.org/10.1186/s13018-023-04396-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38342889"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38342889"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Chenguang Jia, Jianguo Gao, Lianbo Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-877 inhibits the proliferation, migration, and invasion of osteosarcoma cells by targeting gamma-glutamylcyclotransferase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocr J (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1507/endocrj.EJ20-0752"}], "href": "https://doi.org/10.1507/endocrj.EJ20-0752"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34121038"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34121038"}]}]}]}
Synonyms MIR-877, MIRN877, HSA-MIR-877, MIRNA877
NCBI Gene ID 100126314
API
Download Associations
Predicted Functions View MIR877's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR877's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR877's ARCHS4 Predicted Functions.

Functional Associations

MIR877 has 448 functional associations with biological entities spanning 6 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 16 datasets.

Click the + buttons to view associations for MIR877 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR877 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR877 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR877 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR877 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
CTD Gene-Disease Associations diseases associated with MIR877 gene/protein from the curated CTD Gene-Disease Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR877 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR877 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR877 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR877 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of MIR877 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of MIR877 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR877 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR877 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of MIR877 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR877 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR877 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.